Cardiac Resynchronization Therapy for Heart Failure
نویسندگان
چکیده
In the current issue of Circulation, Anand and colleagues representing the COMPANION (The Comparison of Medical Therapy, Pacing and Defibrillation in Heart Failure) Investigators have brought forward compelling data that emphasize the substantial morbidity benefit of cardiac resynchronization therapy (CRT) in patients with moderately severe to severe heart failure. Unlike other studies that have reported reductions in heart failure hospitalizations, Anand et al have accounted for the competing risk of death and variations in follow-up time and surmised that CRT resulted in 44% (optimal pharmacological therapy plus CRT [CRT-P]) and 41% (optimal pharmacological therapy plus CRT with defibrillator [CRT-D]) reductions in heart failure– related hospitalizations. Remarkably, the benefit was seen within days to weeks and was a sustained effect throughout the trial.1 By our calculations using the reported heart failure hospitalization rates (0.73 for optimal pharmacological therapy [OPT], 0.43 for CRT-D, and 0.41 for CRT-P), the number needed to treat with CRT to reduce 1 hospitalization is 4. This is a remarkable benefit for any evidence-based heart failure therapy. These data are sufficiently compelling that when aggregated with the known survival benefits ascribed to CRT, at least some of the residual concerns about efficacy for this device-based intervention should be assuaged. On the basis of these findings, the time may now have come to fundamentally change practice and to more avidly adhere to already extant class I indications for CRT in patients with class III or IV heart failure, with a prolonged QRS, and who are already on appropriate background medical therapy.2
منابع مشابه
Cardiac resynchronization therapy for congestive heart failure.
Cardiac resynchronization represents a novel therapeutic strategy for the treatment of congestive heart failure due to systolic dysfunction. Since its modest beginnings in the 1990s, cardiac resynchronization therapy has gained widespread acceptance as a useful adjunct to pharmacologic therapy for congestive heart failure. Randomized trials have consistently shown functional improvement in pati...
متن کاملCardiac Resynchronization Therapy for Heart Failure
The weight of evidence supporting the routine use of cardiac resynchronization therapy, or atrial-synchronized biventricular pacing, as a treatment for patients with moderate-to-severe chronic systolic heart failure and ventricular dyssynchrony is now quite substantial. Results from mechanistic studies, observational evaluations, and randomized, controlled trials have consistently demonstrated ...
متن کاملCardiac resynchronization therapy.
Systolic heart failure is a major problem for Americans today, with 550,000 new cases diagnosed per year, and ultimately contributes to 287,000 deaths annually. While pharmacologic therapy has drastically improved outcomes in patients with systolic heart failure, hospitalizations from systolic heart failure continue to increase and remain a major cost burden. In response to this unmet need, rec...
متن کاملPredictors of Cardiac Resynchronization Therapy Response: The Pivotal Role of Electrocardiogram
Heart failure affects millions of patients all over the world, and its treatment is a major clinical challenge. Cardiac dyssynchrony is common among patients with advanced heart failure. Resynchronization therapy is a major advancement in heart failure management, but unfortunately not all patients respond to this therapy. Hence, many diagnostic tests have been used to predict the response and ...
متن کاملReversible left bundle branch block should be mentioned in cardiac resynchronization therapy; A clinical case report
BACKGROUND Cardiac resynchronization therapy (CRT) is a medical device to help cardiac synchronized contractility by electrical impulses. Improvement of symptoms and left ventricular systolic function, reducing hospital admissions and mortality in patients with moderate to severe heart failure are the main benefits of administration of cardiac resynchronization therapy. CASE REPORT In this ar...
متن کامل[How many patients admitted for heart failure are eligible for cardiac resynchronization therapy? Analysis of the Andalusian Heart Failure Registry (RAIC) study].
INTRODUCTION AND OBJECTIVES The objective was to determine what percentage of patients admitted for heart failure met criteria for cardiac resynchronization therapy. METHODS The study involved registry data on heart failure admissions at 16 public hospitals in Andalusia, Spain between May and July 2004. Criteria for cardiac resynchronization therapy from American College of Cardiology and Ame...
متن کامل